Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by De Santis et al

Annals of the Rheumatic Diseases, vol. 82, pp. e112

Authors 3

1. Sofía Ramiro corresponding Aachen Rheumatology

   Leiden University Medical Center · Zuyderland Medisch Centrum

   Affiliation as printed

   Rheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, The Netherlands

   Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, The Netherlands sofiaramiro@gmail.com

   Rheumatology, Leiden University Medical Center, 2300 RC Leiden, Zuid-Holland, The Netherlands

2. Rémy L.M. Mostard

   Zuyderland Medisch Centrum

   Affiliation as printed

   Department of Pulmonology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands

3. Robert Landewé

   Amsterdam University Medical Centers · Zuyderland Medisch Centrum

   Affiliation as printed

   Rheumatology & Clinical Immunology, Amsterdam Universitair Medische Centra, Duivendrecht, Noord-Holland, The Netherlands

   Rheumatology, Zuyderland Medical Centre Heerlen, Heerlen, Limburg, The Netherlands